DCGI grants marketing authorisation to SII’s qHPV vaccine against cervical cancer
New Delhi, July 12: The Drugs Controller General of India (DCGI) on July 12 granted market authorisation to Serum Institute of India (SII) to manufacture indigenously-developed India’s first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer, official sources said…
Read More
0
